Patsnap Drug Clinical Trial Data API

openapi: 3.2.0
info:
  title: Patsnap Open Platform AI Translation Drug Clinical Trial Data API
  version: 1.0.0
  description: OpenAPI specification for Patsnap Open Platform APIs, including patent search, analytics, and Eureka AI capabilities.
servers:
- url: https://connect.patsnap.com
  description: Patsnap Open Platform API gateway
tags:
- name: Drug Clinical Trial Data
  description: Drug Clinical Trial Data APIs.
paths:
  /synapse/clinical-trial/contact:
    get:
      operationId: b027ClinicalTrialContact
      summary: B027 Clinical trial contact
      description: Obtain clinical trial contact through clinical trial id or registry number
      tags:
      - Drug Clinical Trial Data
      security:
      - bearerAuth: []
      responses:
        '200':
          description: Successful b027 clinical trial contact response.
          content:
            application/json:
              schema:
                $ref: '#/components/schemas/B027ClinicalTrialContactResponse'
        '401':
          description: Unauthorized.
        '403':
          description: Forbidden.
        '404':
          description: Not Found.
      externalDocs:
        description: API Reference documentation
        url: https://open.patsnap.com/devportal/api-reference/synapse/clinical-trial/contact
      parameters:
      - name: clinical_trial_id
        in: query
        required: false
        description: Clinical trial id, obtain this through clinical trial search interface
        schema:
          type: string
          example: 202425a889e52ae802432a8295220e53
          description: Clinical trial id, obtain this through clinical trial search interface
      - name: register_number
        in: query
        required: false
        description: register number
        schema:
          type: string
          example: NCT06498986
          description: register number
  /synapse/clinical-trial/description:
    get:
      operationId: b024ClinicalTrialDescription
      summary: B024 Clinical trial description
      description: Obtain clinical trial description through clinical trial id or registry number
      tags:
      - Drug Clinical Trial Data
      security:
      - bearerAuth: []
      responses:
        '200':
          description: Successful b024 clinical trial description response.
          content:
            application/json:
              schema:
                $ref: '#/components/schemas/B024ClinicalTrialDescriptionResponse'
        '401':
          description: Unauthorized.
        '403':
          description: Forbidden.
        '404':
          description: Not Found.
      externalDocs:
        description: API Reference documentation
        url: https://open.patsnap.com/devportal/api-reference/synapse/clinical-trial/description
      parameters:
      - name: clinical_trial_id
        in: query
        required: false
        description: Clinical trial id, obtain this through clinical trial search interface
        schema:
          type: string
          example: 202425a889e52ae802432a8295220e53
          description: Clinical trial id, obtain this through clinical trial search interface
      - name: register_number
        in: query
        required: false
        description: register number
        schema:
          type: string
          example: NCT06498986
          description: register number
  /synapse/clinical-trial/detail:
    get:
      operationId: b022ClinicalTrialDetail
      summary: B022 Clinical trial basic information
      description: Obtain clinical trial basic information through clinical trial id or registry number
      tags:
      - Drug Clinical Trial Data
      security:
      - bearerAuth: []
      responses:
        '200':
          description: Successful b022 clinical trial basic information response.
          content:
            application/json:
              schema:
                $ref: '#/components/schemas/B022ClinicalTrialDetailResponse'
        '401':
          description: Unauthorized.
        '403':
          description: Forbidden.
        '404':
          description: Not Found.
      externalDocs:
        description: API Reference documentation
        url: https://open.patsnap.com/devportal/api-reference/synapse/clinical-trial/detail
      parameters:
      - name: clinical_trial_id
        in: query
        required: false
        description: Clinical trial id, obtain this through clinical trial search interface
        schema:
          type: string
          example: 202425a889e52ae802432a8295220e53
          description: Clinical trial id, obtain this through clinical trial search interface
      - name: register_number
        in: query
        required: false
        description: Register number
        schema:
          type: string
          example: NCT06498986
          description: Register number
  /synapse/clinical-trial/design:
    get:
      operationId: b026ClinicalTrialDesign
      summary: B026 Clinical trial design
      description: Obtain clinical trial design through clinical trial id or registry number
      tags:
      - Drug Clinical Trial Data
      security:
      - bearerAuth: []
      responses:
        '200':
          description: Successful b026 clinical trial design response.
          content:
            application/json:
              schema:
                $ref: '#/components/schemas/B026ClinicalTrialDesignResponse'
        '401':
          description: Unauthorized.
        '403':
          description: Forbidden.
        '404':
          description: Not Found.
      externalDocs:
        description: API Reference documentation
        url: https://open.patsnap.com/devportal/api-reference/synapse/clinical-trial/design
      parameters:
      - name: clinical_trial_id
        in: query
        required: false
        description: Clinical trial id, obtain this through clinical trial search interface
        schema:
          type: string
          example: 202425a889e52ae802432a8295220e53
          description: Clinical trial id, obtain this through clinical trial search interface
      - name: register_number
        in: query
        required: false
        description: register number
        schema:
          type: string
          example: NCT06498986
          description: register number
  /synapse/clinical-trial/eligibility:
    get:
      operationId: b025ClinicalTrialEligibility
      summary: B025 Clinical trial eligibility
      description: Obtain clinical trial eligibility through clinical trial id or registry number
      tags:
      - Drug Clinical Trial Data
      security:
      - bearerAuth: []
      responses:
        '200':
          description: Successful b025 clinical trial eligibility response.
          content:
            application/json:
              schema:
                $ref: '#/components/schemas/B025ClinicalTrialEligibilityResponse'
        '401':
          description: Unauthorized.
        '403':
          description: Forbidden.
        '404':
          description: Not Found.
      externalDocs:
        description: API Reference documentation
        url: https://open.patsnap.com/devportal/api-reference/synapse/clinical-trial/eligibility
      parameters:
      - name: clinical_trial_id
        in: query
        required: false
        description: Clinical trial id, obtain this through clinical trial search interface
        schema:
          type: string
          example: 202425a889e52ae802432a8295220e53
          description: Clinical trial id, obtain this through clinical trial search interface
      - name: register_number
        in: query
        required: false
        description: register number
        schema:
          type: string
          example: NCT06498986
          description: register number
  /synapse/clinical-trial/related-entity:
    get:
      operationId: b023ClinicalTrialRelatedEntity
      summary: B023 Clinical trial related entity
      description: Obtain clinical trial related entity through clinical trial id or registry number
      tags:
      - Drug Clinical Trial Data
      security:
      - bearerAuth: []
      responses:
        '200':
          description: Successful b023 clinical trial related entity response.
          content:
            application/json:
              schema:
                $ref: '#/components/schemas/B023ClinicalTrialRelatedEntityResponse'
        '401':
          description: Unauthorized.
        '403':
          description: Forbidden.
        '404':
          description: Not Found.
      externalDocs:
        description: API Reference documentation
        url: https://open.patsnap.com/devportal/api-reference/synapse/clinical-trial/related-entity
      parameters:
      - name: clinical_trial_id
        in: query
        required: false
        description: Clinical trial id, obtain this through clinical trial search interface
        schema:
          type: string
          example: 202425a889e52ae802432a8295220e53
          description: Clinical trial id, obtain this through clinical trial search interface
      - name: register_number
        in: query
        required: false
        description: register number
        schema:
          type: string
          example: NCT06498986
          description: register number
  /synapse/ct-result/detail:
    get:
      operationId: b032CtResultDetail
      summary: B032 Drug clinical result basic information
      description: Obtain clinical result data through clinical  result ID
      tags:
      - Drug Clinical Trial Data
      security:
      - bearerAuth: []
      responses:
        '200':
          description: Successful b032 drug clinical result basic information response.
          content:
            application/json:
              schema:
                $ref: '#/components/schemas/B032CtResultDetailResponse'
        '401':
          description: Unauthorized.
        '403':
          description: Forbidden.
        '404':
          description: Not Found.
      externalDocs:
        description: API Reference documentation
        url: https://open.patsnap.com/devportal/api-reference/synapse/ct-result/detail
      parameters:
      - name: ct_result_id
        in: query
        required: false
        description: Clinical trial result ID, obtain this through clinical result search interface
        schema:
          type: string
          example: e8ea588d3590e929a8022420da25d555
          description: Clinical trial result ID, obtain this through clinical result search interface
  /synapse/ct-result/group:
    get:
      operationId: b048CtResultGroup
      summary: B048 Drug clinical result group information
      description: Obtain clinical result group data through clinical  result ID
      tags:
      - Drug Clinical Trial Data
      security:
      - bearerAuth: []
      responses:
        '200':
          description: Successful b048 drug clinical result group information response.
          content:
            application/json:
              schema:
                $ref: '#/components/schemas/B048CtResultGroupResponse'
        '401':
          description: Unauthorized.
        '403':
          description: Forbidden.
        '404':
          description: Not Found.
      externalDocs:
        description: API Reference documentation
        url: https://open.patsnap.com/devportal/api-reference/synapse/ct-result/group
      parameters:
      - name: ct_result_id
        in: query
        required: false
        description: 临床结果ID，通过临床结果检索接口获取
        schema:
          type: string
          example: 5adee5585028aaa5da5982d22a808a99
          description: 临床结果ID，通过临床结果检索接口获取
components:
  schemas:
    B026ClinicalTrialDesign_Outcome:
      type: object
      properties:
        title:
          type: string
          example: Recommended Phase II Dose (RP2D)
          description: Measure
        time_frame:
          type: string
          example: Up to approximately 24 months
          description: Time Frame
        description:
          type: string
          example: The RP2D is defined as the dose level chosen by the sponsor (in consultation with the investigators) for phase II study, based on safety, tolerability, efficacy, PK, and PD data collected during the dose escalation study of BL-B01D1.
          description: Description
        outcome_type:
          type: string
          example: Primary
          description: Outcome Type
    B025ClinicalTrialEligibility_Age:
      type: object
      properties:
        age:
          type: string
          example: 18
          description: Age
        unit:
          type: string
          example: Years
          description: Unit
    B032CtResultDetail_GetClinicalTrialResultResponseDto:
      type: object
      properties:
        drug:
          type: array
          example:
          - drug_id: 2838b95ade834c96b17ac8bcd2b68c27
            display_name:
            - lang: EN
              name: Sotorasib
            - lang: CN
              name: 索托拉西布
          description: Drug
          items:
            $ref: '#/components/schemas/B032CtResultDetail_CommonDrug'
        phase:
          $ref: '#/components/schemas/B032CtResultDetail_CommonDictionary'
        title:
          type: string
          example: Matching-Adjusted Indirect Treatment Comparisons (MAIC) of Sotorasib 960mg (soto960) Plus Panitumumab (pani) Vs. Trifluridine/Tipiracil(T/T) Plus Bevacizumab (bev) in Chemorefractory Metastatic Colorectal Cancer (mCRC)
          description: title
        target:
          type: array
          example:
          - target_id: 8556307199154d34b1f9bc9685f2ec47
            short_name:
            - lang: EN
              name: IL-6RA
            display_name:
            - lang: EN
              name: Interleukin-6 receptor alpha subunit
            - lang: CN
              name: 白细胞介素-6受体α亚基
          description: Target
          items:
            $ref: '#/components/schemas/B032CtResultDetail_CommonTarget'
        biomarker:
          type: array
          example:
          - id: 11acf267a4fc42f392751e023482aac3
            display_name:
            - lang: EN
              name: CTNNB1 Mutation
          description: Biomarker Id
          items:
            $ref: '#/components/schemas/B032CtResultDetail_CommonEntity'
        conclusion:
          type: string
          example: Sotorasib-panitumumab demonstrated acceptable safety with promising efficacy in chemotherapy-refractory KRASG12C-mutated metastatic colorectal cancer.
          description: Conclusion
        related_id:
          type: array
          example:
          - id_type: study_identifier
            id_value: CodeBreaK 300
          description: Study code
          items:
            $ref: '#/components/schemas/B032CtResultDetail_RelatedId'
        ct_result_id:
          type: string
          example: 5400a5a2dee3da90dd52408a3585d805
          description: Clinical Trial Result Id
        organization:
          type: array
          example:
          - display_name:
            - lang: EN
              name: Amgen, Inc.
            - lang: CN
              name: 安进股份有限公司
            organization_id: 11ef8a9e8bf5ca80213a1183511cded3
          description: Organization master entity id view
          items:
            $ref: '#/components/schemas/B032CtResultDetail_CommonOrganization'
        study_design:
          $ref: '#/components/schemas/B032CtResultDetail_StudyDesignDto'
        therapy_type:
          type: array
          example:
          - display_name:
            - lang: EN
              name: Third line
            - lang: CN
              name: 三线
            normalized_id: 62662f0b1d5b3fafabeb571a211e9a31
          description: Therapy type view
          items:
            $ref: '#/components/schemas/B032CtResultDetail_CommonDictionary'
        published_time:
          type: integer
          format: int64
          example: 1719446400000
          description: Publication Date
        register_number:
          type: array
          example:
          - NCT05198934
          description: Register number
        single_or_multi:
          type: string
          example: single_drug
          description: Single or multi, options:single_drug,multiple_drugs
        mechanism_action:
          type: array
          example:
          - short_name:
            - lang: EN
              name: IL-6RA antagonists
            - lang: CN
              name: IL-6RA拮抗剂
            display_name:
            - lang: EN
              name: Interleukin-6 receptor alpha subunit antagonists
            - lang: CN
              name: 白细胞介素-6受体α亚基拮抗剂
            mechanism_id: b30a0bdb2e0bd9c03a908a84588c4217
          description: Mechanism Action
          items:
            $ref: '#/components/schemas/B032CtResultDetail_CommonMechanismAction'
        therapeutic_area:
          type: array
          example:
          - disease_id: 042cbe45c973477b957717ded29ef7b6
            display_name:
            - lang: EN
              name: Nervous System Diseases
            - lang: CN
              name: 神经系统疾病
          description: Therapeutic Area
          items:
            $ref: '#/components/schemas/B032CtResultDetail_CommonDisease'
        condition_disease:
          type: array
          example:
          - disease_id: e35ce4e9b7a846d49e600ce7ac4a7fd6
            display_name:
            - lang: EN
              name: Metastatic Colorectal Carcinoma
            - lang: CN
              name: 转移性结直肠癌
          description: Condition Disease
          items:
            $ref: '#/components/schemas/B032CtResultDetail_CommonDisease'
        general_evaluation:
          $ref: '#/components/schemas/B032CtResultDetail_CommonDictionary'
        original_biomarker:
          type: array
          example:
          - name: IL-6
          description: Original Biomarker
          items:
            $ref: '#/components/schemas/B032CtResultDetail_CommonName'
        overall_enrollment:
          type: integer
          format: int32
          example: 100
          description: Overall enrollment
        register_number_map:
          type: object
          example:
            NCT04737187: 5a4a2ad359d8a855d925943e23a58845
          description: Register number map
        sponsor_organization:
          type: array
          example:
          - display_name:
            - lang: EN
              name: Amgen, Inc.
            - lang: CN
              name: 安进股份有限公司
            organization_id: 11ef8a9e8bf5ca80213a1183511cded3
          description: Sponsor Organization
          items:
            $ref: '#/components/schemas/B032CtResultDetail_CommonOrganization'
        collaborator_organization:
          type: array
          example:
          - display_name:
            - lang: EN
              name: Amgen, Inc.
            - lang: CN
              name: 安进股份有限公司
            organization_id: 11ef8a9e8bf5ca80213a1183511cded3
          description: Collaborator Organization
          items:
            $ref: '#/components/schemas/B032CtResultDetail_CommonOrganization'
    B022ClinicalTrialDetailResponse:
      type: object
      properties:
        data:
          $ref: '#/components/schemas/B022ClinicalTrialDetail_GetClinicalTrialBasicInformationResponseDto'
        status:
          type: boolean
          example: 'false'
          description: Status
        error_msg:
          type: string
          example: The request parameter format is incorrect！
          description: Error Message
        error_code:
          type: integer
          example: '0'
          description: Error Code
      required:
      - status
      - error_code
    B032CtResultDetail_StudyDesignDto:
      type: object
      properties:
        masking:
          type: string
          example: XXXX
          description: Masking
        allocation:
          type: string
          example: XXXX
          description: Allocation
        primary_purpose:
          type: string
          example: XXXX
          description: Primary Purpose
        intervention_model:
          type: string
          example: XXXX
          description: Intervention Model
        allocation_normalized:
          $ref: '#/components/schemas/B032CtResultDetail_CommonDictionary'
        intervention_model_normalized:
          $ref: '#/components/schemas/B032CtResultDetail_CommonDictionary'
    B025ClinicalTrialEligibility_GetClinicalTrialEligibilityResponseDto:
      type: object
      properties:
        gender:
          type: string
          example: All
          description: Sexes
        max_age:
          $ref: '#/components/schemas/B025ClinicalTrialEligibility_Age'
        min_age:
          $ref: '#/components/schemas/B025ClinicalTrialEligibility_Age'
        register_number:
          type: string
          example: NCT06498986
          description: Trial Number
        exclude_criteria:
          type: string
          example: <ul><li>1. Patients with prior systemic therapy;</li><li>2. Previous treatment with EGFR-TKI;</li><li>3. Participants who participated in any other clinical trial within 4 weeks before the trial dose;</li><li>4. Traditional Chinese medicine (TCM) which had received radiotherapy within 4 weeks before the first use of the study drug and had anti-tumor indications within 2 weeks before the first use of the study drug;</li><li>5. Had undergone major surgery within 4 weeks before the first dose;</li><li>6. History of severe heart disease or cerebrovascular disease;</li><li>7. Unstable thrombotic events requiring therapeutic intervention within 6 months before screening; Infusion-related thrombosis was excluded;</li><li>8. QT prolongation, complete left bundle branch block, III degree atrioventricular block, frequent and uncontrollable arrhythmia;</li><li>9. Previous history of interstitial lung disease requiring steroid therapy, or current ILD or grade ≥2 radiation pneumonitis;</li><li>10. Complicated pulmonary diseases leading to clinically severe respiratory function impairment;</li><li>11. Severe systemic infection within 4 weeks before screening;</li><li>12. Patients at risk for active autoimmune disease or with a history of autoimmune disease;</li><li>13. Other malignant tumors within 5 years before the first dose;</li><li>14. HIV antibody positive, active tuberculosis, active hepatitis B virus infection, or hepatitis C virus infection;</li><li>15. Hypertension poorly controlled by two antihypertensive drugs;</li><li>16. Patients with poor glycemic control;</li><li>17. Patients with massive effusions, or effusions with obvious symptoms, or poorly controlled effusions;</li><li>18. Patients with active central nervous system metastases;</li><li>19. Imaging examination showed that the tumor had invaded or enveloped the large blood vessels in the abdomen, chest, neck, and pharynx;</li><li>20. Severe unhealed wound, ulcer, or fracture within 4 weeks before consent signing;</li><li>21. Sign a four weeks before there were clinically significant bleeding or bleeding tendency obviously subjects;</li><li>22. Previous history of allogeneic stem cell, bone marrow or organ transplantation;</li><li>23. Patients with a history of allergy to recombinant humanized antibodies or to any of the excipients of BL-B01D1;</li><li>24. A history of severe neurological or psychiatric illness;</li><li>25. Pregnant or lactating women;</li><li>26. Subjects who were scheduled to receive live vaccine or received live vaccine within 28 days before study randomization;</li><li>27. Other conditions for participation in the trial were not considered appropriate by the investigator.</li>
          description: Exclusion Criteria
        include_criteria:
          type: string
          example: '<ul><li>1. Voluntarily sign the informed consent and follow the requirements of the protocol;</li><li>2. No gender limit;</li><li>3. Age ≥18 years old;</li><li>4. Expected survival time ≥3 months;</li><li>5. Patients with histologically and/or cytologically confirmed locally advanced or metastatic non-small cell lung cancer;</li><li>6. Documentation of EGFR sensitive mutations detected from tumor tissue or blood samples;</li><li>7. Consent to provide archived tumor tissue or fresh tissue samples from primary or metastatic sites within 2 years for biomarker testing;</li><li>8. At least one measurable lesion meeting the RECIST v1.1 definition was required;</li><li>9. ECOG ≤1;</li><li>10. Toxicity of previous antineoplastic therapy has returned to ≤ grade 1 defined by NCI-CTCAE v5.0;</li><li>11. No severe cardiac dysfunction, left ventricular ejection fraction ≥50%;</li><li>12. The level of organ function must meet the requirements on the premise that blood transfusion is not allowed within 14 days before the screening period and no cell growth factor drugs are allowed;</li><li>13. Blood coagulation function: international standardization ratio of 1.5 or less, and the part activated clotting time live enzymes acuities were 1.5 x ULN;</li><li>14. Urine protein ≤2+ or ≤1000mg/24h;</li><li>15. Fertile female subjects or male subjects with fertile partners must use highly effective contraception from 7 days before the first dose until 6 months after the dose. Female subjects of childbearing potential had to have a negative serum pregnancy test within 7 days before the first dose.</li>'
          description: Inclusion Criteria
        clinical_trial_id:
          type: string
          example: 202425a889e52ae802432a8295220e53
          description: Clinical Trial ID
        healthy_volunteers:
          type: string
          example: 'No'
          description: 'Accepts Healthy Volunteers, enumeration values: Yes, No'
    B025ClinicalTrialEligibilityResponse:
      type: object
      properties:
        data:
          $ref: '#/components/schemas/B025ClinicalTrialEligibility_GetClinicalTrialEligibilityResponseDto'
        status:
          type: boolean
          example: 'false'
          description: Status
        error_msg:
          type: string
          example: The request parameter format is incorrect！
          description: Error Message
        error_code:
          type: integer
          example: '0'
          description: Error Code
      required:
      - status
      - error_code
    B032CtResultDetail_CommonDisease:
      type: object
      properties:
        disease_id:
          type: string
          example: 06a9082fe1ec4c97bea31d888b9cfdce
          description: Disease ID
        display_name:
          type: array
          example:
          - lang: EN
            name: Uveitic Macular Edema
          - lang: CN
            name: 葡萄膜炎黄斑水肿
          description: Disease Name, Referencing "CommonName"
          items:
            $ref: '#/components/schemas/B032CtResultDetail_CommonName'
    B026ClinicalTrialDesign_GetClinicalTrialDesignResponseDto:
      type: object
      properties:
        masking:
          type: string
          example: None (Open Label)
          description: Masking
        outcome:
          type: array
          example:
          - title: Recommended Phase II Dose (RP2D)
            time_frame: Up to approximately 24 months
            description: The RP2D is defined as the dose level chosen by the sponsor (in consultation with the investigators) for phase II study, based on safety, tolerability, efficacy, PK, and PD data collected during the dose escalation study of BL-B01D1.
            outcome_type: Primary
          - title: Objective response rate (ORR)
            time_frame: Up to approximately 24 months
            description: ORR is defined as the percentage of participants, who has a CR (disappearance of all target lesions) or PR (at least a 30% decrease in the sum of diameters of target lesions). The percentage of participants who experiences a confirmed CR or PR is according to RECIST 1.1.
            outcome_type: Primary
          description: Outcome Measures
          items:
            $ref: '#/components/schemas/B026ClinicalTrialDesign_Outcome'
        allocation:
          type: string
          example: N/A
          description: Allocation
        enrollment:
          type: array
          example:
          - enrollment: '40'
          description: Enrollment
          items:
            $ref: '#/components/schemas/B026ClinicalTrialDesign_Enrollment'
        start_date:
          $ref: '#/components/schemas/B026ClinicalTrialDesign_DateItem'
        study_type:
          type: string
          example: Interventional
          description: 'Study Type, enumeration values: "Prevention", "Expanded Access", "Health Services Research", "Interventional", "Diagnosis", "Cause", "Observational", "Basic Science", "Unknown", "Others"'
        completion_date:
          $ref: '#/components/schemas/B026ClinicalTrialDesign_DateItem'
        primary_purpose:
          type: string
          example: Treatment
          description: Primary Purpose
        register_number:
          type: string
          example: NCT06498986
          description: Trial Number
        arm_intervention:
          type: array
          example:
          - intervention:
            - intervention_name: BL-B01D1
              intervention_type: Drug
              intervention_description: Administration by intravenous infusion for a cycle of 3 weeks.
            - intervention_name: Osimertinib Mesylate Tablets
              intervention_type: Drug
              intervention_description: Oral administration, 80mg daily for a cycle of 3 weeks.
            design_group_type: Experimental
            design_group_title: BL-B01D1+Osimertinib Mesylate Tablets
            design_group_description: Participants receive BL-B01D1+Osimertinib Mesylate Tablets in the first cycle (3 weeks). Participants with clinical benefit could receive additional treatment for more cycles. The administration will be terminated because of disease progression or intolerable toxicity occurring or other reasons.
          description: Arms and Interventions
          items:
            $ref: '#/components/schemas/B026ClinicalTrialDesign_ArmIntervention'
        clinical_trial_id:
          type: string
          example: 202425a889e52ae802432a8295220e53
          description: Clinical Trial ID
        first_posted_date:
          type: integer
          format: int64
          example: 1720742400000
          description: First Posted Date
        intervention_model:
          type: string
          example: Single Group Assignment
          description: Intervention Model
        primary_completion_date:
          $ref: '#/components/schemas/B026ClinicalTrialDesign_DateItem'
    B023ClinicalTrialRelatedEntity_CommonTarget:
      type: object
      properties:
        target_id:
          type: string
          example: 1c2067e5ab054a8995f73efcfcf56207
          description: Target ID
        short_name:
          type: array
          example:
          - lang: EN
            name: VEGF
          description: Target Short Name, Referencing "CommonName"
          items:
            $ref: '#/components/schemas/B023ClinicalTrialRelatedEntity_CommonName'
        display_name:
          type: array
          example:
          - lang: EN
            name: Vascular endothelial growth factor
          - lang: CN
            name: 血管内皮生长因子
          description: Target Full Name, Referencing "CommonName"
          items:
            $ref: '#/components/schemas/B023ClinicalTrialRelatedEntity_CommonName'
    B027ClinicalTrialContactResponse:
      type: object
      properties:
        data:
          $ref: '#/components/schemas/B027ClinicalTrialContact_GetClinicalTrialContactResponseDto'
        status:
          type: boolean
          example: 'false'
          description: Status
        error_msg:
          type: string
          example: The request parameter format is incorrect！
          description: Error Message
        error_code:
          type: integer
          example: '0'
          description: Error Code
      required:
      - status
      - error_code
    B023ClinicalTrialRelatedEntity_CommonOrganization:
      type: object
      properties:
        display_name:
          type: array
          example:
          - lang: EN
            name: Roche Holding AG
          - lang: CN
            name: 罗氏
          description: Organization Name, Referencing "CommonName"
         

# --- truncated at 32 KB (58 KB total) ---
# Full source: https://raw.githubusercontent.com/api-evangelist/patsnap/refs/heads/main/openapi/patsnap-drug-clinical-trial-data-api-openapi.yml